QuickVue Advance® pH and Amines test
Navigation Links
QuickVue Advance® pH and Amines test
| Products | QuickVue Advance® pH and Amines test |
| Company | Quidel Corporation |
| Item | QuickVue Advance® pH and Amines test |
| Features | |
| Description | Layered Thin Film technology is here! LTF™ (Layered Thin Film) technology is a revolutionary, new rapid point-of-care test platform that is easy to read, extremely precise and as small and thin as a credit card. What is Infectious Vaginitis? Infectious vaginitis is the number one reason women visit their physician. Vaginal discharge and odor are inconvenient to the patient, because these symptoms are often recurring. Up until now, the microscope has been the main tool, used by the physician, in diagnosing many conditions. Bacterial vaginosis or BV is the most common among the several disease states known as infectious vaginitis. The QuickVue Advance pH and Amines test contains two qualitative, colorimetric tests for use in the characterization of a vaginal fluid sample: a pH test and a test that detects alkali volatilizable amines in vaginal fluid. In conjunction with the clinical evaluation of the vaginal fluid, 3 of the 4 Amsel criteria will be assessed. |
| Info | Quidel Corporation Customer Service: (800) 874-1517 Web site: http://www.quidel.com |
Related medicine products :
1. QuickVue Influenza test
2. QuickVue Influenza A+B test
3. QuickVue+ Infectious Mononucleosis test
4. QuickVue H.pylori gII test
5. QuickVue In-Line Strep A Test
6. QuickVue Advance® G. vaginalis test.
7. Advance® Posterior Stabilized Total Knee Systems
8. Aromatic Primary Amines, Urine
9. Stimulant Amines Detection
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products:(Date:12/2/2008)..., Dec. 3 Minimally inva...se method for removal of self-inflicted,foreign o...t on "self-,embedding disorder," or self-injury a...scents. The findings will be presented today at th...orth America (RSNA). , "Radiologists are in...
(Date:12/2/2008)..., Mich., Dec. 3 Representatives fr...Machine.com ) paid a visit to the Shriners,Hospit...te to an,extraordinary, albeit unique, cause; The...eelchair-friendly exercise equipment to the first ... (Photo: http://www.newscom.com/cgi-bin/prnh/...
(Date:12/2/2008)...AN FRANCISCO, Calif., Dec. 1 diaDe...k approval for the automated format of the,PLAC T...(R) Test, capable of,running on a wide range of c...the U.S. Food & Drug Administration (FDA) in D...hipment of the CE Marked PLAC Test to Europe. , ...
(Date:12/2/2008)...ren of farm workers are three times as likely as a...her poor children to be uninsured, according to a ...rics & Adolescent Medicine, one of the JAMA/Archiv...ariety of health challenges, according to backgrou...group that already has suboptimal access to pediat...
Breaking Medicine News(10 mins):Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 2Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 3Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:1/3 of farm workers' children lack health insurance 2...ws that people who have optic nerve damage are at ...volved 25 people with visual impairment. The parti...d for 14 days, and their results were compared wit...l sight. Researchers discovered those with optic n...
...ng the use of hormone replacement therapy among br...cause results indicate an unacceptably high rate o...barked on the study in part because more women are...ject to the same menopausal symptoms as other wome...
...common complaint and one that causes excessive abs... program // for these patients aimed at returning ...th lower back pain avoid exercise because of the p...e with low back pain can benefit from regular exer...
...s is a chronic inflammatory disease of the immune ... latest findings researchers say // people consumi...risk for rheumatoid arthritis . Researchers compa...awn from a research sample of over 25,000 men and ...
Other Medicine News:(Date:12/1/2008)...GO, Dec. 2 A study has ...new technique for imaging the breast, is not affec... status, two factors that limit the effectiveness ...r. Results will be presented today at the annual m...a (RSNA). , , "The ability of PEM to detec...
(Date:12/1/2008)...phatasia Treated With ENB-0040 at Children,s Hospi... MONTREAL, Dec. 1 Enobia Pharma, a...eloping novel therapeutics for serious bone disord... in its clinical program for hypophosphatasia was ...Therapy (ERT) with ENB-0040 for the treatment of t...
(Date:12/1/2008)...duled for Tuesday, December 9 at 11:00 am ET to Di...SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-...q: SNSS ), a biopharmaceutical company focused o...ology therapeutics, today announced new data from ... (AML) will be presented during the 50th American ...
(Date:11/28/2008)...November 28 German biotech company...cialized HIV monitoring and,AIDS patient follow-u...s. In,the year 2008, 2.5 million patient tests ha...ighly affordable "CyFlow" system, supporting alrea...S. Due to introduction of the,Partec innovation, ...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2TopoTarget Successfully Buys Back Full Control of Belinostat 4752 1TopoTarget Successfully Buys Back Full Control of Belinostat 4752 2TopoTarget Successfully Buys Back Full Control of Belinostat 4752 3TopoTarget Successfully Buys Back Full Control of Belinostat 4752 4TopoTarget Successfully Buys Back Full Control of Belinostat 4752 5TopoTarget Successfully Buys Back Full Control of Belinostat 4752 6TopoTarget Successfully Buys Back Full Control of Belinostat 4752 7Fufeng Announces 2007 Annual Results 4750 1Fufeng Announces 2007 Annual Results 4750 2Fufeng Announces 2007 Annual Results 4750 3Ortho Evra Patch Makers Settling Cases 4749 1Ortho Evra Patch Makers Settling Cases 4749 2Europe spends nearly twice as much as US on nanotech risk research 4747 1Europe spends nearly twice as much as US on nanotech risk research 4747 2[1] New Mammography Technology Effective in Detecting Breast Cancer[0] Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease[0] Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH[0] German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
... Therapeutics Inc.,(OTCBB:MIVT) (FWB:MIV), a leadi...ings and advanced drug delivery systems for,cardio...ces, today,announced that a recent Company sponsor...tific,s certified bare metal stent platform,which...r-free drug,delivery system met critical "FDA Draf...
...rograms to be Presented, SOUTH SAN FRANCISCO, Cali...inetics, Incorporated announced,today that four po...ed at the 2007 Annual Meeting of the American Asso... April 14- 18, 2007 in,Los Angeles, CA. These post...ytokinetics and will present data evaluating,ispin...
Other Medicine Technology:MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 2MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 3MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |